Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Elevance Health ( (ELV) ) is now available.
On May 13, 2026, Elevance Health, Inc. shareholders held their annual meeting, where they elected three directors—Gail K. Boudreaux, Robert L. Dixon, Jr., and Deanna D. Strable—to new three-year terms ending in 2029. The meeting was conducted with a quorum of more than 194 million shares represented, underscoring broad investor participation in the company’s governance process.
Shareholders also approved on an advisory basis the company’s executive compensation program and ratified Ernst & Young LLP as independent auditor for the 2026 fiscal year, signaling continued support for Elevance Health’s leadership and financial oversight. A shareholder proposal requesting an independent study on the impact of banning corporate contributions to partisan 527 political groups was decisively rejected, indicating investors’ preference to maintain the company’s current approach to political spending oversight.
The most recent analyst rating on (ELV) stock is a Hold with a $360.00 price target. To see the full list of analyst forecasts on Elevance Health stock, see the ELV Stock Forecast page.
Spark’s Take on ELV Stock
According to Spark, TipRanks’ AI Analyst, ELV is a Outperform.
The score is driven primarily by solid financial performance (strong scale and cash flow despite margin compression) and constructive technical momentum. Valuation is reasonable at a mid-teens P/E, while the latest earnings call supports the outlook via raised EPS guidance and buybacks but is tempered by the CMS accrual and ongoing Medicaid/Carelon pressure.
To see Spark’s full report on ELV stock, click here.
More about Elevance Health
Elevance Health, Inc. is a U.S. health insurance and health services company that operates in the managed care industry. The company provides medical benefit plans and related services to individuals, employers, and government-sponsored programs, positioning itself as a major player in the commercial and public health insurance markets.
Average Trading Volume: 1,899,278
Technical Sentiment Signal: Buy
Current Market Cap: $85.41B
See more insights into ELV stock on TipRanks’ Stock Analysis page.